Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,424 GBX | -1.62% | -1.70% | +5.60% |
May. 23 | British business decisions which hinge on election outcome | RE |
May. 23 | BRITISH AMERICAN TOBACCO : UBS remains Neutral | ZD |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- One of the major weak points of the company is its financial situation.
- With an enterprise value anticipated at 3.23 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.60% | 69.52B | B- | ||
+5.92% | 157B | B- | ||
+7.39% | 21.26B | A- | ||
+30.15% | 6.69B | B- | ||
+85.38% | 2.45B | - | C+ | |
-4.99% | 1.78B | - | ||
-4.26% | 1.75B | - | D+ | |
-30.90% | 1.31B | - | B+ | |
0.00% | 653M | - | - | |
+24.24% | 583M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BATS Stock
- Ratings British American Tobacco p.l.c.